Thymosin Alpha-1 – 10mg Research Compound

Thymosin Alpha-1 (10mg) — Research Compound

Thymosin Alpha-1 (Tα1) is a synthetic analogue of a naturally occurring thymic peptide that functions as a major immune system modulator. It interacts with Toll-like receptors (TLRs) to stimulate the production of T-cells and enhance the activity of natural killer (NK) cells. Research primarily focuses on its ability to balance the immune response, investigating its role in both boosting defences against pathogens and modulating overactive inflammatory pathways.

Findings from early-stage clinical trials have reported:

• Enhanced T-cell maturation and increased cytokine production, such as interferon-gamma, observed in research models
  
• Reductions in viral replication rates reported in studies focused on chronic viral infections
  
• Improvements in vaccine response and antibody production noted in experimental cohorts
  
• Observed modulations in systemic inflammation markers reported in animal studies
  

Researchers study Thymosin Alpha-1 to explore its utility as an immunotherapeutic tool in the context of immune deficiency and chronic infection. By investigating its influence on the major histocompatibility complex (MHC) and dendritic cell function, it serves as a valuable model for understanding how the body coordinates cellular immunity. Its high degree of tolerability in research settings makes it a focal point for studies into age-related immune senescence.

Available Formats:
This compound is available as a vial of lyophilised powder, or can be ordered in a disposable pen, a reusable pen, or a cartridge for an existing reusable pen system.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use